Spatial Transcriptomics and Mechanisms of Immune Checkpoint Inhibitor-Associated Interstitial Nephritis
Year: 2026
Type: article
Study design: Observational Study
Abstract: Introduction Immune checkpoint inhibitor-associated acute interstitial nephritis (ICI-AIN) is the most common finding on histopathology among patients with ICI-associated acute kidney injury (ICI-AKI). Patients with ICI-AIN often have T cell-dominant infiltration of the kidney and high tissue levels of CXCR3 ligands like CXCL9, 10, and 11; however, the mechanisms of inflammation in ICI-AIN are not well-understood. Methods We applied a sub-cellular spatial transcriptomics platform (Xenium Prime 5K) to compare the cellular composition of kidney biopsy tissue from patients with ICI-AIN with ICI-treated patients with acute tubular necrosis (ICI-ATN). Results Across 8 kidney biopsy specimens (4 with ICI-AIN, 4 with ICI-ATN), we analyzed 332,000 cells, comprising kidney parenchymal cells and infiltrating immune cells. Using a spatially aware cellular neighborhood-based classification, we identified cellular niches corresponding to each part of the nephron, in addition to unique fibrotic and inflammatory niches. Gene pathway analysis identified interferon-gamma (IFN-γ)/STAT1 signaling as strongly increased in ICI-AIN compared to ICI-ATN. While all inflammatory niches were overrepresented in ICI AIN, CD8+ T cell infiltration and proinflammatory myeloid cells were the dominant immune niches. Spatial niche crosstalk analysis revealed that CD8+ T cell-derived IFN-γ likely induced a proinflammatory program in myeloid cells, with increased production of CXCL9, 10, and 11. Furthermore, IFN-γ signaling in ICI-AIN was associated with reduced oxidative phosphorylation in kidney tubular niches. Conclusions Spatial transcriptomics thus revealed novel insights into key differences in the pathophysiology of ICI-AIN versus ICI-ATN, with IFN-γ-producing CD8 + T cells as potential drivers of ICI-AIN.
Source: Kidney International Reports
Authors: Qian Qin, Lennard Ostendorf, Sophia L. Wells, Ce Gao, Miles Tran, Firasat M. Alikhan, Xiwen Zhang, Api Chewcharat, Robert S. Rider, Sean A. Prell, Raad B. Chowdhury, Astrid Weins, Sujal I. Shah, Kavita Mistry, Teresa Bowman, Alexandra-Chloe Villani, Nicole R. LeBoeuf, Umut Selamet, Katherine Scovner Ravi, Elad Sharon, David E. Leaf, Dennis G. Moledina, Meghan E. Sise, Iwijn De Vlaminck, Deepak A. Rao, Kevin Wei, Shruti Gupta
Institutions: Brigham and Women's Hospital, Harvard University, Humboldt-Universität zu Berlin, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Charité – Universitätsmedizin Berlin, Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center, Dana-Farber/Harvard Cancer Center, Massachusetts General Hospital, Yale University, Cornell University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,800
Funders: Burroughs Wellcome Fund, Brigham and Women's Hospital, Massachusetts General Hospital, Partners Healthcare, European Commission, Uniwersytet Marii Curie-Skłodowskiej, National Institutes of Health, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases
Awards: G3560578127, A Notch-mediated fibrogenic program drives treatment failure in rheumatoid arthritis, Association of Dialysate Bicarbonate with Hemodynamic Instability and Arrhythmia, Incident Hemodialysis Electrolyte Analysis and Rhythm Trends (IHEART), Novel Pathways and Therapeutic Targets for Cisplatin-Associated Acute Kidney Injury, Dana-Farber/Harvard Cancer Center, Early Detection and Treatment of Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (HSCT-TMA)
OpenAlex ID: W7196924162
